GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » PharmaTher Holdings Ltd (XCNQ:PHRM) » Definitions » Total Debt per Share

PharmaTher Holdings (XCNQ:PHRM) Total Debt per Share : C$0.00 (As of Feb. 2024)


View and export this data going back to 2021. Start your Free Trial

What is PharmaTher Holdings Total Debt per Share?

C$0.00 (As of Feb. 2024)

Total Debt per Share is calculated as total debt divided by Shares Outstanding (EOP). Total debt is calculated as Long-Term Debt & Capital Lease Obligation plus Short-Term Debt & Capital Lease Obligation. PharmaTher Holdings's Total Debt Per Share for the quarter that ended in Feb. 2024 was C$0.00.

PharmaTher Holdings Total Debt per Share Historical Data

The historical data trend for PharmaTher Holdings's Total Debt per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

PharmaTher Holdings Total Debt per Share Chart

PharmaTher Holdings Annual Data
Trend May21 May22 May23
Total Debt per Share
- - -

PharmaTher Holdings Quarterly Data
Aug20 Nov20 Feb21 May21 Aug21 Nov21 Feb22 May22 Aug22 Nov22 Feb23 May23 Aug23 Nov23 Feb24
Total Debt per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

PharmaTher Holdings Total Debt per Share Calculation

PharmaTher Holdings's Total Debt Per Share for the fiscal year that ended in May. 2023 is calculated as:

Total Debt Per Share=(Long-Term Debt & Capital Lease Obligation+Short-Term Debt & Capital Lease Obligation)/Shares Outstanding (EOP)
=(0.00+0.00)/88.17
=0.00

PharmaTher Holdings's Total Debt Per Share for the quarter that ended in Feb. 2024 is calculated as:

Total Debt Per Share=(Long-Term Debt & Capital Lease Obligation+Short-Term Debt & Capital Lease Obligation)/Shares Outstanding (EOP)
=(0.00+0.00)/88.17
=0.00

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

PharmaTher Holdings Total Debt per Share Related Terms

Thank you for viewing the detailed overview of PharmaTher Holdings's Total Debt per Share provided by GuruFocus.com. Please click on the following links to see related term pages.

PharmaTher Holdings (XCNQ:PHRM) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » PharmaTher Holdings Ltd (XCNQ:PHRM) » Definitions » Total Debt per Share
Comparable Companies
XCNQ:COOL XCNQ:MDMA XCNQ:ASEP TSXV:QPT XCNQ:TELI NEOE:BMND TSX:AEZS TSXV:NRX XCNQ:BLAB TSXV:KNE OCSE:NOVO B VRTX REGN ASX:CSL SGEN XKRX:207940 MRNA XBRU:ARGX HKSE:02269 BNTX
Traded in Other Exchanges
PHRRF:USA
Address
82 Richmond Street East, Toronto, ON, CAN, M5C 1P1
Website
https://www.pharmather.com
PharmaTher Holdings Ltd is a specialty life sciences company focused on the research and development of psychedelic pharmaceuticals for FDA approval to treat mental health, neurological, and pain disorders. Its product pipeline includes Ketamine, KETABET, Microneedle Patch among others.
Executives
Fabio Chianelli Director, Senior Officer

PharmaTher Holdings (XCNQ:PHRM) Headlines

No Headlines